Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9327759rdf:typepubmed:Citationlld:pubmed
pubmed-article:9327759lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9327759lifeskim:mentionsumls-concept:C0012155lld:lifeskim
pubmed-article:9327759lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:9327759lifeskim:mentionsumls-concept:C0015684lld:lifeskim
pubmed-article:9327759lifeskim:mentionsumls-concept:C0065058lld:lifeskim
pubmed-article:9327759lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:9327759lifeskim:mentionsumls-concept:C0522534lld:lifeskim
pubmed-article:9327759pubmed:issue9lld:pubmed
pubmed-article:9327759pubmed:dateCreated1997-11-13lld:pubmed
pubmed-article:9327759pubmed:abstractTextStudies that have shown adverse effects of trans-unsaturated fatty acids on plasma lipoprotein (a) [Lp(a)] levels have used levels of trans-fatty acid that are higher than those in the average U.S. diet. This study was conducted to clarify the effects on Lp(a) of trans-fatty acids levels commonly found in U.S. diets. Lp(a) levels were measured in a double-blind study of 29 men and 29 women who ate 4 controlled diets in random order for 6 weeks each. Fatty acids represented 39% to 40% of energy. The diets were: (1) Oleic (16.7% of energy as oleic acid); (2) Moderate trans (3.8% of energy as trans-monoenes, approximately the trans content of the U.S. diet); (3) High trans (6.6% of energy as trans-monoenes); (4) Saturated (16.2% of energy as lauric plus myristic plus palmitic acids). The Saturated diet lowered Lp(a) levels significantly (by 8% to 11%). Compared to the Oleic diet, the trans diets had no adverse effect on Lp(a) levels when all subjects were considered collectively. A subset with initially high levels of Lp(a) (> or = 30 mg/dL), however, responded to the High trans diet with a slight (5%) increase in Lp(a) levels relative to the Oleic and Moderate trans diets. Thus, in amounts commonly found in the typical U.S. diet, saturated fatty acids consistently decrease Lp(a) concentrations. The adverse effects of replacing cis- with trans-fatty acids are only suggestive and are restricted to high trans intakes in subjects with high Lp(a) levels.lld:pubmed
pubmed-article:9327759pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9327759pubmed:languageenglld:pubmed
pubmed-article:9327759pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9327759pubmed:citationSubsetIMlld:pubmed
pubmed-article:9327759pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9327759pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9327759pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9327759pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9327759pubmed:statusMEDLINElld:pubmed
pubmed-article:9327759pubmed:monthSeplld:pubmed
pubmed-article:9327759pubmed:issn1079-5642lld:pubmed
pubmed-article:9327759pubmed:authorpubmed-author:SchaeferE JEJlld:pubmed
pubmed-article:9327759pubmed:authorpubmed-author:ClevidenceB...lld:pubmed
pubmed-article:9327759pubmed:authorpubmed-author:MuesingR ARAlld:pubmed
pubmed-article:9327759pubmed:authorpubmed-author:JuddJ TJTlld:pubmed
pubmed-article:9327759pubmed:authorpubmed-author:WittesJJlld:pubmed
pubmed-article:9327759pubmed:authorpubmed-author:JennerJ LJLlld:pubmed
pubmed-article:9327759pubmed:authorpubmed-author:LichtensteinA...lld:pubmed
pubmed-article:9327759pubmed:authorpubmed-author:SunkinM EMElld:pubmed
pubmed-article:9327759pubmed:issnTypePrintlld:pubmed
pubmed-article:9327759pubmed:volume17lld:pubmed
pubmed-article:9327759pubmed:ownerNLMlld:pubmed
pubmed-article:9327759pubmed:authorsCompleteYlld:pubmed
pubmed-article:9327759pubmed:pagination1657-61lld:pubmed
pubmed-article:9327759pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:9327759pubmed:meshHeadingpubmed-meshheading:9327759-...lld:pubmed
pubmed-article:9327759pubmed:meshHeadingpubmed-meshheading:9327759-...lld:pubmed
pubmed-article:9327759pubmed:meshHeadingpubmed-meshheading:9327759-...lld:pubmed
pubmed-article:9327759pubmed:meshHeadingpubmed-meshheading:9327759-...lld:pubmed
pubmed-article:9327759pubmed:meshHeadingpubmed-meshheading:9327759-...lld:pubmed
pubmed-article:9327759pubmed:meshHeadingpubmed-meshheading:9327759-...lld:pubmed
pubmed-article:9327759pubmed:meshHeadingpubmed-meshheading:9327759-...lld:pubmed
pubmed-article:9327759pubmed:meshHeadingpubmed-meshheading:9327759-...lld:pubmed
pubmed-article:9327759pubmed:meshHeadingpubmed-meshheading:9327759-...lld:pubmed
pubmed-article:9327759pubmed:meshHeadingpubmed-meshheading:9327759-...lld:pubmed
pubmed-article:9327759pubmed:meshHeadingpubmed-meshheading:9327759-...lld:pubmed
pubmed-article:9327759pubmed:year1997lld:pubmed
pubmed-article:9327759pubmed:articleTitlePlasma lipoprotein (a) levels in men and women consuming diets enriched in saturated, cis-, or trans-monounsaturated fatty acids.lld:pubmed
pubmed-article:9327759pubmed:affiliationDiet and Human Performance Laboratory, Beltsville Human Nutrition Research Center, USDA, MD 20705-2350, USA. Bev@bhnrc.arsusda.govlld:pubmed
pubmed-article:9327759pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9327759pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:9327759pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9327759pubmed:publicationTypeRandomized Controlled Triallld:pubmed